ArticleGlobal bioethics = Problemi di bioetica2026
What might Confucius say? Digital doppelgängers for people who are newly dead, dying, or comatose.
Article in Global bioethics = Problemi di bioetica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper explores what Confucius might say about the use of generative AI-based digital doppelgängers in healthcare for patients who are newly dead, dying, or comatose. We focus on the use of these technologies to support patients' family members, loved ones, and surrogate decision-makers. Since Confucian approaches are largely missing from bioethics discussions of AI-based digital doppelgängers and patient preference predictors, this paper helps to fill an important gap. Section I introduces three cases involving digital doppelgängers representing people who are newly dead, dying, or comatose. Section II considers a Confucian response to the three cases. Section III applies Confucian values to a further situation, where the digital doppelgänger for a comatose patient functions as a patient preference predictor helping with a surrogate decision for a comatose patient. Section IV sets forth ethical benchmarks for using digital doppelgängers in healthcare. Section V recommends proceeding with caution and highlights the importance of further understanding the benefits and risks of using these tools in diverse cultural contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.